Venture capital firms Prolog Ventures and Holton Capital Group have provided funds to launch Sequoia Vaccines, a spin-out tackling urinary-tract infections from drug-discovery company Sequoia Sciences.
Venture capital firms Prolog Ventures and Holton Capital Group have provided funds to launch Sequoia Vaccines, a spin-out tackling urinary-tract infections from drug-discovery company Sequoia Sciences.